Education Archive

HPV test of cure: More accurate, less costly

A Dutch team has demonstrated that combining hrHPV testing with cytology following treatment for CIN improves clinical outcome and reduces overall costs compared with the current standard of cytology alone.

Management with cytology alone after CIN treatment showed a specificity for detection of residual/recurrent CIN of 80% compared with 91% with cytology plus hrHPV. The sensitivity was 86% with cytology alone and 100% with cytology plus hrHPV.

Total health-care costs were lower with the dual test approach for women at low risk of disease recurrence, because they were safely able to skip the 12-month follow-up visit.